It is strictly prohibited to build any application that operates within a clinical workflow. Yet what does Google do? They congratulate it, they promote it, they invite it into their Showcase, and they actively encourage it.
https://discuss.ai.google.dev/t/medasr-outstanding-feedback-from-clinicians/169929
Google is profiting from promoting medical AI while explicitly disclaiming all liability in their own Terms of Service. The HAI-DEF Showcase is nothing but global marketing; the systems featured there would be illegal for clinical use in the EU and the US because they are not certified medical devices.
Google is knowingly promoting non-compliant medical AI tools just to drive profit, while hiding behind legal disclaimers to escape accountability for the catastrophic risks they are creating for patients. This is pure, hypocritical garbage.
The Medavo application advertises itself as an “Offline Medical AI Scribe” and is designed to transcribe medical conversations. This functionality qualifies as a medical device in every jurisdiction — EU, USA, Middle East, Asia — because it produces documentation that influences clinical decision‑making. The definition of a medical device is global and not region‑dependent: IMDRF, WHO, EU MDR, and the FDA all classify software that generates clinical documentation as a medical device.
Medavo holds no CE certification, no FDA 510(k) clearance, and no internationally recognized medical device authorization. Therefore, the product is considered an “unauthorized medical device” in every country.
The Apple App Store is globally responsible for medical device compliance, regardless of whether the user is located in the EU, the USA, or Dubai. Platform responsibility is not region‑limited.
Google’s own Health AI Developer Foundations documentation explicitly states that MedGemma/MedASR is “NOT an approved medical device,” and that clinical use of Google models is prohibited worldwide. This prohibition is global and not restricted to the EU or the USA.
Despite this, two Google employees (posting with Google badges and official Google profiles) openly congratulated the use of MedASR in a real clinical workflow and the clinical launch of the Medavo application. This is not user‑generated content — it is Google‑generated content that directly endorses the clinical use of a non‑certified medical device.
This constitutes a violation of Google’s own global policy and amounts to platform‑level clinical endorsement, regardless of whether the user is in Dubai or anywhere else. Public validation of clinical workflows by Google employees creates worldwide legal exposure.
If Medavo makes an error (e.g., hallucinating a drug name or symptom) and a patient is harmed, the liability chain is clear:
Clinicpoints Ltd. — the manufacturer of the software
Apple — the platform that allowed distribution of a non‑certified medical AI
Google — the platform whose official employees publicly endorsed its clinical use
This is not region‑dependent, not Dubai‑dependent, and not location‑dependent. It is a global medical device compliance issue.
It is provably NOT the user (Mary_Colm) who posted the HAI‑DEF link in the thread — it was the Google employee (fmahvar). This means Google invited Medavo into the clinical HAI‑DEF Showcase. This is evidence that Google is supporting clinical use. Google’s own policy explicitly forbids clinical use:
“MedGemma is NOT an approved medical device.”
“You may NOT use the Services in clinical practice.”
MedGemma is NOT an approved medical device. You may NOT use it in clinical practice. This means the AI cannot be used by doctors, clinics, hospitals, or on patients. It is prohibited for clinical purposes. The Google employee invited it into the clinical Showcase and requested clinical testing. From that point on, this is incitement. And it is proven.
They are promoting and encouraging the clinical use of a software (Medavo) that they fully know is not authorized for medical use. If an AI like this makes a mistake — hallucinates a diagnosis or a medication dose — a human life could depend on it.
The app can exist, but it cannot be used in a clinical setting — not even in Dubai. And the people in the post openly stated that they are using it live in a clinic. This is a serious problem for them.
Clinicpoints sells clinical functions such as SOAP notes, clinical summaries, referrals, care plans, EHR, telehealth, patient communication, care planning and prescription-related features – all of which fall under the category of medical devices. These require CE or FDA approval, which they do not have. Google blocks their clinical use because of this. Apple, on the other hand, allows them under a ‘productivity/dictation’ label, even though the company’s own website openly advertises clinical care features. This is misleading, unlawful, and such a product should never be sold for clinical purposes anywhere in the world.
Clinicpoints openly advertises prescription writing, care plans, and EHR features without any regulatory approval, while Google washes its hands of the situation — even as their engineers buddy up with them on the forum and invite them to the Showcase. It’s blatant, shameless hypocrisy on Google’s part. I’m disgusted by them.
This infographic is literally the perfect one‑image summary of the entire scandal. Anyone who hasn’t read a single minute of your legal breakdown can look at this, and in five seconds they understand exactly how hypocritical and schizophrenic the fraud Google is pulling.
Based on Google’s own public communications and employee reactions, the company’s potential liability in a future damages lawsuit could also be examined, as these statements may fall under the legal doctrine of Constructive Knowledge.
They sell it as a medical app for doctors, but it has no certification or regulatory approval. That’s deception — it’s basically a scam.
